"Amantadine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An antiviral that is used in the prophylactic or symptomatic treatment of influenza A. It is also used as an antiparkinsonian agent, to treat extrapyramidal reactions, and for postherpetic neuralgia. The mechanisms of its effects in movement disorders are not well understood but probably reflect an increase in synthesis and release of dopamine, with perhaps some inhibition of dopamine uptake.
Descriptor ID |
D000547
|
MeSH Number(s) |
D02.455.426.100.050.035
|
Concept/Terms |
Amantadine- Amantadine
- 1-Aminoadamantane
- 1 Aminoadamantane
- Adamantylamine
Amanta-Sulfate-AZU- Amanta-Sulfate-AZU
- Amanta Sulfate AZU
- AmantaSulfateAZU
- Amantadin AZU
- AZU, Amantadin
|
Below are MeSH descriptors whose meaning is more general than "Amantadine".
Below are MeSH descriptors whose meaning is more specific than "Amantadine".
This graph shows the total number of publications written about "Amantadine" by people in this website by year, and whether "Amantadine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 |
1997 | 0 | 1 | 1 |
1998 | 1 | 0 | 1 |
1999 | 0 | 1 | 1 |
2004 | 1 | 0 | 1 |
2007 | 1 | 0 | 1 |
2012 | 1 | 0 | 1 |
2014 | 0 | 1 | 1 |
2015 | 1 | 0 | 1 |
2016 | 0 | 1 | 1 |
2017 | 1 | 1 | 2 |
2018 | 1 | 0 | 1 |
2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Amantadine" by people in Profiles.
-
EASE LID 2: A 2-Year Open-Label Trial of Gocovri (Amantadine) Extended Release for Dyskinesia in Parkinson's Disease. J Parkinsons Dis. 2020; 10(2):543-558.
-
Amantadine Did Not Positively Impact Cognition in Chronic Traumatic Brain Injury: A Multi-Site, Randomized, Controlled Trial. J Neurotrauma. 2018 10 01; 35(19):2298-2305.
-
Potential Impact of Amantadine on Aggression in Chronic Traumatic Brain Injury. J Head Trauma Rehabil. 2017 Sep/Oct; 32(5):308-318.
-
Antiviral therapy for respiratory viral infections in immunocompromised patients. Expert Rev Anti Infect Ther. 2017 04; 15(4):401-415.
-
Drug-Induced Dyskinesia, Part 1: Treatment of Levodopa-Induced Dyskinesia. Drugs. 2016 May; 76(7):759-77.
-
Amantadine Effect on Perceptions of Irritability after Traumatic Brain Injury: Results of the Amantadine Irritability Multisite Study. J Neurotrauma. 2015 Aug 15; 32(16):1230-8.
-
Delivery of negatively charged liposomes into the atherosclerotic plaque of apolipoprotein E-deficient mouse aortic tissue. J Liposome Res. 2014 Sep; 24(3):182-90.
-
Placebo-controlled trial of amantadine for severe traumatic brain injury. N Engl J Med. 2012 Mar 01; 366(9):819-26.
-
Likely amantadine-induced livedo reticularis in a child. Pediatr Dermatol. 2012 May-Jun; 29(3):329-30.
-
Subjective and cardiovascular effects of cocaine during treatment with amantadine and baclofen in combination. Psychiatry Res. 2007 Aug 30; 152(2-3):205-10.